Recursion Pharmaceuticals Inc vs Warner Music Group Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Warner Music Group Corp trades at $25.08 (market cap $13.12B). The key difference: Warner Music Group Corp is far larger — about 7.2× Recursion Pharmaceuticals Inc's market cap, and Warner Music Group Corp pays a 3.19% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | WMG | |
|---|---|---|
Market Cap | $1.81B | $13.12B |
Sector | Health | Media |
52-Week High | $6.79 | $34.72 |
52-Week Low | $2.84 | $23.65 |
Enterprise Value | $1.33B | $17.42B |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →